A detailed history of Bdo Wealth Advisors, LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Bdo Wealth Advisors, LLC holds 1,750 shares of EXEL stock, worth $60,952. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,750
Previous 1,750 -0.0%
Holding current value
$60,952
Previous $33,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020

BUY
$14.46 - $21.8 $25,305 - $38,150
1,750 New
1,750 $30,000
Q2 2018

Aug 27, 2018

SELL
$18.56 - $22.45 $1,855 - $2,245
-100 Closed
0 $0
Q1 2018

May 23, 2018

BUY
$22.15 - $31.89 $2,215 - $3,189
100 New
100 $2,000

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $11.2B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Bdo Wealth Advisors, LLC Portfolio

Follow Bdo Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bdo Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bdo Wealth Advisors, LLC with notifications on news.